Home
This site is intended for healthcare professionals
Advertisement

Research Skills Medical Student Journal Club - November (Cancer Clinical Trials)

13th Nov 2024
7:00 - 8:00pm (GMT)
13th Nov 2024
7:00 - 8:00pm (GMT)
Hosted on MedAll
Attendance certificate available
This event has ended. Similar events
Free
ONLINE

Catch-up content

2

Description

Looking to sharpen your critical appraisal skills in a fun and supportive space? Our monthly journal club is the perfect place for you - no research experience required.

Theme of the month: Clinical trials in oncology

Paper this month: Combining pembrolizumab and chemotherapy vs placebo and chemotherapy for first time treatment of advanced triple-negative breast cancer: KEYNOTE-355 trial results

Session structure:

  • 20 minute presentation of a clinical trial paper by David Withey, 4th year medical student with a PhD in Cancer Sciences
  • Group discussion of the paper
  • Introduction to critical appraisal and randomised controlled trials

Summary

The November session of our Research Skills Medical Student Journal Club focuses on cancer clinical trials. Perfect for anybody looking to fine-tune their critical appraisal skills in an enjoyable, supportive setting and requires no prior research experience. The topic for discussion is the combination of pembrolizumab and chemotherapy versus placebo and chemotherapy shown in the KEYNOTE-355 trial results. The session starts with a 20-min presentation by David Withey, a 4th-year medical student, with a Cancer Sciences PhD, followed by a group discussion and an introduction to critical appraisal and randomised controlled trials.

Generated by MedBot

Learning objectives

  1. To understand and interpret the results of the KEYNOTE-355 clinical trial on the treatment of advanced triple-negative breast cancer.
  2. To develop and strengthen skills pertaining to critical appraisal, specifically in the context of clinical trials in oncology.
  3. To enhance knowledge about the process and methodologies behind randomized controlled trials in the medical field.
  4. To foster active participation in in-depth group discussions about oncology clinical trials and develop collaborative learning skills.
  5. To comprehend the importance and impact of combining therapies such as pembrolizumab and chemotherapy in oncology clinical trials.
Generated by MedBot
57 people attended this event. Sign up today and join your colleagues at future events.

Speaking at this event

Advertisement
Advertisement
View all

Similar events and on demand videos

Advertisement
 
13th Nov 2024
7:00 - 8:00pm (GMT)
Hosted on MedAll
Attendance certificate available
This event has ended. Similar events
Free
ONLINE